Skip to content
TrialScanner

NCT03053466

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

Phase 1CompletedAPLMLead

Registry record

Lead sponsor
Apollomics (Australia) Pty. Ltd.
Conditions
Solid Tumor; Microsatellite Instability; Mismatch Repair Deficiency; Cancer of Unknown Primary Site
Primary completion
Feb 25, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03053466 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.